HbA1c variability associated with dementia risk in people with type 2 diabetes
Authors:
Open Access
- 3 July 2024
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (8) , 5561-5569
Abstract
INTRODUCTION: Although poor glycemic control is associated with dementia, it is unknown if variability in glycemic control, even in those with optimal glycosylated hemoglobin A1c (HbA1c) levels, increases dementia risk.METHODS: Among 171,964 people with type 2 diabetes, we evaluated the hazard of dementia association with long‐term HbA1c variability using five operationalizations, including standard deviation (SD), adjusting for demographics and comorbidities.RESULTS: The mean baseline age was 61 years (48% women). Greater HbA1c SD was associated with greater dementia hazard (adjusted hazard ratio = 1.15 [95% confidence interval: 1.12, 1.17]). In stratified analyses, higher HbA1c SD quintiles were associated with greater dementia hazard among those with a mean HbA1c < 6% (P = 0.0004) or 6% to 8% (P < 0.0001) but not among those with mean HbA1c ≥ 8% (P = 0.42).DISCUSSION: Greater HbA1c variability is associated with greater dementia risk, even among those with HbA1c concentrations at ideal clinical targets. These findings add to the importance and clinical impact of recommendations to minimize glycemic variability.Highlights: We observed a cohort of 171,964 people with type 2 diabetes (mean age 61 years). This cohort was based in Northern California between 1996 and 2018. We examined the association between glycosylated hemoglobin A1c (HbA1c) variability and dementia risk. Greater HbA1c variability was associated with greater dementia hazard. This was most evident among those with normal–low mean HbA1c concentrations.Keywords
Funding Information
- National Institute on Aging (R01‐AG067199, R01‐AG063391)
- National Institutes of Health (R01‐DK129320)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK092924)
This publication has 33 references indexed in Scilit:
- Glycemic Control Over Multiple Decades and Dementia Risk in People With Type 2 DiabetesJAMA Neurology, 2023
- Long-term glycemic variability and risk of adverse health outcomes in patients with diabetes: A systematic review and meta-analysis of cohort studiesDiabetes Research and Clinical Practice, 2022
- New Insights into the Role of Visit-to-Visit Glycemic Variability and Blood Pressure Variability in Cardiovascular Disease RiskCurrent Cardiology Reports, 2021
- The effect of long-term past glycemic control on executive function among patients with type 2 diabetes mellitusDiabetology International, 2019
- Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 DiabetesThe American Journal of the Medical Sciences, 2018
- Dementia prevention, intervention, and careThe Lancet, 2017
- The impact of glycemic variability on diabetic peripheral neuropathyEndocrine, 2016
- Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudyThe Lancet Neurology, 2011
- Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes MellitusJAMA, 2009
- Risk of dementia in diabetes mellitus: a systematic reviewThe Lancet Neurology, 2006